SG11202100756RA - Cell culture strategies for modulating protein glycosylation - Google Patents
Cell culture strategies for modulating protein glycosylationInfo
- Publication number
- SG11202100756RA SG11202100756RA SG11202100756RA SG11202100756RA SG11202100756RA SG 11202100756R A SG11202100756R A SG 11202100756RA SG 11202100756R A SG11202100756R A SG 11202100756RA SG 11202100756R A SG11202100756R A SG 11202100756RA SG 11202100756R A SG11202100756R A SG 11202100756RA
- Authority
- SG
- Singapore
- Prior art keywords
- cell culture
- protein glycosylation
- modulating protein
- culture strategies
- strategies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2887—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
- C07K2317/41—Glycosylation, sialylation, or fucosylation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/02—Atmosphere, e.g. low oxygen conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2523/00—Culture process characterised by temperature
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862717751P | 2018-08-10 | 2018-08-10 | |
PCT/US2019/045900 WO2020033827A1 (en) | 2018-08-10 | 2019-08-09 | Cell culture strategies for modulating protein glycosylation |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202100756RA true SG11202100756RA (en) | 2021-02-25 |
Family
ID=67902575
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202100756RA SG11202100756RA (en) | 2018-08-10 | 2019-08-09 | Cell culture strategies for modulating protein glycosylation |
Country Status (14)
Country | Link |
---|---|
US (1) | US20210238644A1 (en) |
EP (1) | EP3833688A1 (en) |
JP (1) | JP2021533760A (en) |
KR (1) | KR20210043618A (en) |
CN (1) | CN112752769A (en) |
AR (1) | AR114548A1 (en) |
AU (1) | AU2019319970A1 (en) |
BR (1) | BR112021002480A2 (en) |
CA (1) | CA3107038A1 (en) |
IL (1) | IL280553A (en) |
MX (1) | MX2021001521A (en) |
SG (1) | SG11202100756RA (en) |
TW (1) | TW202021985A (en) |
WO (1) | WO2020033827A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4352094A1 (en) | 2021-06-07 | 2024-04-17 | Amgen Inc. | Using fucosidase to control afucosylation level of glycosylated proteins |
CN115651953A (en) * | 2022-11-17 | 2023-01-31 | 康日百奥生物科技(苏州)有限公司 | Antibody medicine, preparation method and cell culture medium |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
ES2206447T3 (en) | 1991-06-14 | 2004-05-16 | Genentech, Inc. | HUMANIZED ANTIBODY FOR HEREGULINE. |
ATE375365T1 (en) | 1998-04-02 | 2007-10-15 | Genentech Inc | ANTIBODIES VARIANTS AND FRAGMENTS THEREOF |
US6194551B1 (en) | 1998-04-02 | 2001-02-27 | Genentech, Inc. | Polypeptide variants |
AU2005233387B2 (en) * | 2004-04-15 | 2011-05-26 | Glycofi, Inc. | Production of galactosylated glycoproteins in lower eukaryotes |
JP5058483B2 (en) * | 2005-09-14 | 2012-10-24 | オリンパス株式会社 | Long-term or continuous detection method for biological samples |
BRPI1015019A2 (en) * | 2009-04-20 | 2018-02-14 | Pfizer | glycosylation control of protein and related compositions and methods. |
US20110053223A1 (en) * | 2009-08-14 | 2011-03-03 | Robert Bayer | Cell culture methods to make antibodies with enhanced adcc function |
EP2511293A1 (en) * | 2011-04-13 | 2012-10-17 | LEK Pharmaceuticals d.d. | A method for controlling the main complex N-glycan structures and the acidic variants and variability in bioprocesses producing recombinant proteins |
EP2702077A2 (en) * | 2011-04-27 | 2014-03-05 | AbbVie Inc. | Methods for controlling the galactosylation profile of recombinantly-expressed proteins |
US9493744B2 (en) | 2012-06-20 | 2016-11-15 | Genentech, Inc. | Methods for viral inactivation and other adventitious agents |
WO2014170866A2 (en) * | 2013-04-18 | 2014-10-23 | Dr. Reddy's Laboratories Limited | Process of obtaining glycoprotein composition with increased galactosylation content |
EP3024922A4 (en) * | 2013-07-23 | 2017-03-29 | Biocon Limited | Methods for controlling fucosylation levels in proteins |
HU231463B1 (en) * | 2015-08-04 | 2024-01-28 | Richter Gedeon Nyrt. | Method for increasing the galactose content of recombinant proteins |
-
2019
- 2019-08-09 EP EP19765827.1A patent/EP3833688A1/en active Pending
- 2019-08-09 KR KR1020217007090A patent/KR20210043618A/en active Search and Examination
- 2019-08-09 AU AU2019319970A patent/AU2019319970A1/en not_active Abandoned
- 2019-08-09 SG SG11202100756RA patent/SG11202100756RA/en unknown
- 2019-08-09 CN CN201980063223.3A patent/CN112752769A/en active Pending
- 2019-08-09 CA CA3107038A patent/CA3107038A1/en active Pending
- 2019-08-09 BR BR112021002480-8A patent/BR112021002480A2/en not_active Application Discontinuation
- 2019-08-09 JP JP2021506970A patent/JP2021533760A/en active Pending
- 2019-08-09 WO PCT/US2019/045900 patent/WO2020033827A1/en unknown
- 2019-08-09 MX MX2021001521A patent/MX2021001521A/en unknown
- 2019-08-09 AR ARP190102268A patent/AR114548A1/en unknown
- 2019-08-12 TW TW108128647A patent/TW202021985A/en unknown
-
2021
- 2021-02-01 IL IL280553A patent/IL280553A/en unknown
- 2021-02-10 US US17/172,528 patent/US20210238644A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
KR20210043618A (en) | 2021-04-21 |
US20210238644A1 (en) | 2021-08-05 |
AR114548A1 (en) | 2020-09-16 |
AU2019319970A1 (en) | 2021-03-11 |
MX2021001521A (en) | 2021-04-19 |
CN112752769A (en) | 2021-05-04 |
JP2021533760A (en) | 2021-12-09 |
TW202021985A (en) | 2020-06-16 |
EP3833688A1 (en) | 2021-06-16 |
BR112021002480A2 (en) | 2021-07-27 |
CA3107038A1 (en) | 2020-02-13 |
WO2020033827A1 (en) | 2020-02-13 |
IL280553A (en) | 2021-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3647407A4 (en) | Cell culture device | |
KR102318115B9 (en) | Cell culture system | |
SG11202010543QA (en) | Yeast proteins | |
MX2020012356A (en) | Overexpression of n-glycosylation pathway regulators to modulate glycosylation of recombinant proteins. | |
IL290590A (en) | Cell culture methods | |
IL280553A (en) | Cell culture strategies for modulating protein glycosylation | |
EP3894540A4 (en) | Cell isolation for use in automated bioreactors | |
EP4013780A4 (en) | Car-t cells specific for modified proteins in extracellular spaces | |
IL292145A (en) | Methods for characterizing host-cell proteins | |
EP3858974A4 (en) | Cell culture chip | |
EP3747985A4 (en) | Cell culture container | |
IL284658A (en) | Heterodimeric proteins for modulating gamma delta t cells | |
EP4058565A4 (en) | Methods for reprogramming cells | |
EP3861098A4 (en) | Cell culture bioreactor | |
CA185441S (en) | Cell culture insert | |
IL286419A (en) | Novel selection marker-comprising cell line and uses thereof for protein production | |
EP3842513A4 (en) | Cell incubator | |
EP4056673A4 (en) | Cell culture device | |
EP3987920A4 (en) | Water culture block | |
EP3990610A4 (en) | Cell culture system | |
EP4048783C0 (en) | Modified cell | |
EP3798297A4 (en) | 3d cell automated incubator | |
CA185442S (en) | Cell culture insert | |
EP3929275A4 (en) | Cell culture chip | |
SG11202007023TA (en) | Cell culture module |